All Topics

Hashimoto's Thyroiditis

Hashimoto's thyroiditis is the most common cause of hypothyroidism in the United States — an autoimmune condition in which the immune system gradually destroys the thyroid gland. With proper management, most patients live completely normal lives.

Hashimoto's thyroiditis, also called chronic lymphocytic thyroiditis or autoimmune thyroiditis, is a condition in which the body's immune system mistakenly attacks the thyroid gland. Over time, this immune assault damages thyroid tissue and reduces hormone production, leading to hypothyroidism. It affects women seven to ten times more often than men and is the leading cause of underactive thyroid in iodine-sufficient countries. Dr. Guttler has diagnosed and managed thousands of Hashimoto's patients over his 50-year career.

Patient Story

Linda, 38

Linda had been exhausted for two years. She gained 15 pounds despite eating carefully, felt cold all the time, and her hair was thinning noticeably. Three doctors told her labs were 'normal.' When she finally saw Dr. Guttler, he checked her TPO antibodies — they were over 1,200. Her TSH was 6.8, technically in the 'normal' range by some lab standards but clearly symptomatic for her. Dr. Guttler started low-dose levothyroxine, targeting a TSH of 1–2. Within three months Linda felt like herself again. 'I wish someone had checked those antibodies years ago,' she said.

What Is Hashimoto's Thyroiditis?

Hashimoto's is an autoimmune disease in which T lymphocytes infiltrate the thyroid gland and trigger chronic inflammation. The immune system produces antibodies — most notably thyroid peroxidase antibodies (TPO-Ab) and thyroglobulin antibodies (TgAb) — that attack thyroid proteins. Over years to decades, this destroys enough thyroid tissue to cause overt hypothyroidism.

Symptoms

Early Hashimoto's may cause no symptoms at all, or a brief hyperthyroid phase ('Hashitoxicosis') as damaged cells release stored hormone. As the gland fails, classic hypothyroid symptoms emerge: fatigue, weight gain, cold intolerance, constipation, dry skin, hair loss, brain fog, depression, and slowed heart rate. A goiter (enlarged thyroid) is present in many but not all patients.

Diagnosis

Diagnosis requires a TSH level, free T4, and TPO antibody measurement. Elevated TPO antibodies confirm autoimmune thyroid disease even when TSH is still normal. Thyroid ultrasound typically shows a heterogeneous, hypoechoic gland with a characteristic 'moth-eaten' appearance. Fine-needle aspiration is not needed for diagnosis but may be performed if a nodule is present.

Treatment

When TSH is elevated and the patient is symptomatic, levothyroxine (T4) replacement is the standard treatment. Dr. Guttler individualizes the target TSH — typically 1–2 mIU/L for symptomatic patients — rather than accepting any value within the broad laboratory reference range. Some patients feel better with the addition of liothyronine (T3) or combination T4/T3 therapy, an area of ongoing research and clinical judgment.

Hashimoto's and Thyroid Cancer Risk

Patients with Hashimoto's have a slightly increased risk of thyroid lymphoma and papillary thyroid cancer. Any new nodule in a Hashimoto's patient warrants ultrasound evaluation and, if indicated, fine-needle aspiration biopsy. Regular follow-up with thyroid ultrasound every 1–2 years is prudent.

Living with Hashimoto's

Hashimoto's is a lifelong condition, but it is highly manageable. Most patients on appropriate levothyroxine therapy feel completely well. Gluten-free diets, selenium supplementation, and stress reduction have been studied with mixed results; Dr. Guttler discusses these options individually with patients. The key is regular monitoring of TSH and free T4, and dose adjustments as the disease progresses.

Copyright © 1999-2026 GoDaddy, LLC. All rights reserved.

Privacy PolicyTerms of UseDisclaimerGoDaddy Privacy

References to any specific company, product or services on this Site are not controlled by GoDaddy.com LLC and do not constitute or imply its association with or endorsement of third party advertisers.